Reuters exclusively reported that Danaher Corp (DHR.N) is in the lead to acquire Abcam Plc, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings.
Related stories
Exclusives | Americas
Read more
Peru plans bond sales to finance ballooning fiscal deficit, minister says
29 January 2025
News First | Americas
Read more
Boeing warns of bigger-than-expected $4 billion quarterly loss; shares drop
24 January 2025
Exclusives | Americas
Read more